Technical Analysis for SRPT - Sarepta Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 121.78 0.38% 0.46
SRPT closed up 1.73 percent on Thursday, January 17, 2019, on 80 percent of normal volume. It was able to find support at its 50 day moving average. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical SRPT trend table...

Date Alert Name Type % Chg
Jan 17 Death Cross Bearish 0.38%
Jan 17 200 DMA Support Bullish 0.38%
Jan 17 50 DMA Support Bullish 0.38%
Jan 17 Multiple of Ten Bullish Other 0.38%
Jan 17 Outside Day Range Expansion 0.38%
Jan 17 Up 3 Days in a Row Strength 0.38%
Jan 16 200 DMA Support Bullish 2.11%
Jan 16 Crossed Above 50 DMA Bullish 2.11%
Jan 16 MACD Bullish Centerline Cross Bullish 2.11%
Jan 16 Doji - Bearish? Reversal 2.11%

Older signals for SRPT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. Its lead product candidate is eteplirsen, an antisense PMO-based therapeutic, which is in Phase IIb clinical development for the treatment of individuals with Duchenne muscular dystrophy. The company is also involved in developing treatments that are in Phase I clinical trials for infectious diseases, including AVI-7288 for Marburg virus; and AVI-7100 for H1N1 influenza virus. In addition, it focuses on developing preclinical research product candidates for the treatment of other neuromuscular, infectious, and rare diseases. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.
Is SRPT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 176.5
52 Week Low 50.68
Average Volume 1,045,608
200-Day Moving Average 118.8242
50-Day Moving Average 118.4846
20-Day Moving Average 110.686
10-Day Moving Average 116.822
Average True Range 6.491
ADX 26.94
+DI 28.0984
-DI 14.1982
Chandelier Exit (Long, 3 ATRs ) 105.957
Chandelier Exit (Short, 3 ATRs ) 114.68299999999999
Upper Bollinger Band 125.1343
Lower Bollinger Band 96.2377
Percent B (%b) 0.87
BandWidth 26.106825
MACD Line 0.7107
MACD Signal Line -1.169
MACD Histogram 1.8797
Fundamentals Value
Market Cap 7.79 Billion
Num Shares 64.2 Million
EPS -2.34
Price-to-Earnings (P/E) Ratio -51.85
Price-to-Sales 53.98
Price-to-Book 6.98
PEG Ratio 231.25
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 131.70
Resistance 3 (R3) 131.58 127.99 129.97
Resistance 2 (R2) 127.99 125.35 128.06 129.39
Resistance 1 (R1) 124.66 123.72 126.33 124.78 128.82
Pivot Point 121.07 121.07 121.91 121.14 121.07
Support 1 (S1) 117.74 118.43 119.41 117.86 113.82
Support 2 (S2) 114.15 116.80 114.22 113.25
Support 3 (S3) 110.82 114.15 112.67
Support 4 (S4) 110.94